CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: Common co-signals induced by CD80 and CD86

International Immunology

Volumn 8, Issue 10, 1996, Pages 1609-1616

  Cefai, Daniel ^a,b   Cai, Yun Cai ^a,c   Hu, Hui ^a,b   Rudd, Christopher ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CHO CELL; DEPENDENT PERSONALITY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CHO CELLS; CRICETINAE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION;

EID: 0029842021     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.10.1609     Document Type: Article

References (56)

1. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy Cell f71:1065.
2. Jenkins, M. K. and Johnson, J. G. 1993. Molecules involved in T cell co-stimulation, Curr. Opin. Immunol. 5:367.
3. Linsley, P. S. and Ledbetter, J. A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
4. Freeman, G. J., Borriello, F., Hodes, R. J., Reiser, H., Hathcock, K. S., Laszlo, G., McKnight, A. J., Kim, J., Du, L., Lombard, D. B., Gray, G. S., Nadler, L. M. and Sharpe, A. H. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
5. Shahinian, A., Pfeffer, K., Lee, K. P., Kuendig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B. and Mak, T. W. 1993 Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
6. Green, J. M., Noel, P. J., Sperling, A. I., Walunas, T. L., Gray, S. G., Bluestone, J. A. and Thompson, C. B. 1994, Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
7. cc chain of the IL-2 receptor. Science 299:1039.
8. + T cells by B7-transfected melanoma cells. Science 259:368.
9. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M. Freeman, G. J. and Glimcher, L. H. 1993. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl Acad. Sci. USA 90:56.
10. Chen, L., Ashe, S., Brady, W. A., Hellstroem, I., Hellstroem, K. E., Ledbetter, J. A., McGowan, P. and Linsley, P. S. 1992. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1
11. Guerder, S., Picarella, D. E., Linsley, P. S. and Flavell, R. A. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl Acad. Sci. USA 91:5138.
12. Lindstein, T., June, C. H., Ledbetter, J. A., Stella, G. and Thompson, C. B. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway Science 244:339.
13. Fraser, J. D., Irving, B. A., Crabtree, G. R. and Weiss, A. 1991. Regulation of interleukin-2 enhancer activity by the T cell accessory molecule CD28. Science 251:313.
14. de Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P. and Ceuppens, J. L. 1993. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin 4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120.
15. Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M , Gray, G. S., Thompson, C. B. and June, C. H. 1993 Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151:3489.
16. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr, Lombard, L. A., Gray, G. S. and Nadler, L. M. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
17. Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P. and Modes, R. J. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
18. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes, R. J. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function, J. Exp. Med. 180:631.
19. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76 .
20. Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A. and Peach, R. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
21. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D. and Azuma, M. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
22. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
23. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A. 1995. Differential effects of anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
24. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X.-Y., Rennert, P. D., Gray, G. S., Gribben, J. G. and Nadler, L. M. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
25. Truitt, K. E., Hicks, C. M. and Imboden, J. B. 1994. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol-3-kinase in Jurkat T cells. J. Exp. Med. 179:1071
26. Prasad, K. V. S., Cai, Y.-C., Raab, M., Duckworth, B., Cantley, L., Shoelson, S. E. and Rudd, C. E. 1994. T cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-MeT Xaa-Met motif. Proc. Natl Acad. Sci. USA 91:2834.
27. August, A. and DuPont, B. 1994. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 6:769.
28. August, A., Gibson, S., Kawakami,Y., Kawakami, T., Mills, G. B. and Dupont, B. 1994. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T cell line, Proc. Natl Acad. Sci, USA 91:9347.
29. ras Eur. J. Immunol. 25:1044.
30. Pages, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., and Olive, D. 1994. Binding of phosphatidyl-3-OH kinase to CD28 is required for T cell signalling. Nature 369:327.
31. Cai, Y.-C., Céfai, D., Schneider, H., Raab, M., Nabavi, N. and Rudd, C. E. 1995. Selective CD28 pYMNM mutations implicate phosphatidylinositol 3-kinase in CD28 mediated co-stimulation. Immunity 3 417.
32. Truitt, K. E., Shi, J., Gibson, S., Segal, L. G., Mills, G. B. and Imboden, J. B. 1995 CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J. Immunol. 155:4702.
33. Crooks, M. E. C., Littman, D. R., Carter, R. H., Fearon, C. T., Weiss, A. and Stein, P. H. 1995. CD28-mediated co-stimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol. Cell. Biol. 15:6820.
34. Lu, Y., Phillips, C. A. and Trevillyan, J. M. 1995. Phosphatidylinositol 3-kinase is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin. Eur. J. Immunol. 25:533.
35. Ueda, Y., Levine, B. L., Huang, M. L., Freeman, G. F., Nadler, L. M., June, C. H. and Ward, S. G. 1995. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7:957.
36. Sykulev, Y., Brunmark, A., Tsomides, T. J., Kageyama, S., Jackson, M., Peterson, P. A. and Heisen, H. N. 1994. High affinity reactions between antigen-specific T cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex cClass I proteins. Proc. Natl Acad. Sci. USA 91:11487.
37. fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor binding protein GRB-2 and T cell specific kinase ITK: implications for T cell co-stimulation. Proc. Natl Acad. Sci. USA 92:8891.
38. 2+independent costimulatory activity Eur. J. Immunol. 24:2732.
39. Hutchcroft, J. E., Franklin, D. P., Tsai, B., Harrison-Findik, D., Vartocovski, L. and Bierer, B. 1995. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T lymphocyte surface receptor. Proc. Natl Acad. Sci. USA 92:8808.
40. Chen, C., Gault, A., Shen, L. and Nabavi, N. 1994. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 152:4929.
41. Chen, C., Denise, D. A., Gault, A., Connaughton, S. E., Powers, G. D., Godfrey, D. I. and Nabavi, N. 1994. Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes. J. Immunol. 152:2105.
42. Gillis, S., Frem, M. M., Ou, W. and Smith, K. A. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027.
43. Songyang, Z., Shoelson, S. E., Chandhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B. and Cantley, L. C. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767.
44. lck J. Biol. Chem. 268:27420.
45. Nakanishi, H., Brewer, K. A. and Exton, J. H. 1993. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 268:13.
46. Toker, A., Meyer M., Reddy, K. K., Falck, J. R., Aneja, R., Aneja, S., Parra, A., Burns, D. J., Bellas, L. M. and Cantley, L. C. 1994. Activation of protein kinase C family members by the novel polyphosphoinositides Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3. J. Biol. Chem. 269:32358.
47. Bell, R. M. 1986. Protein kinase C activation by diacylglycerol second messengers. Cell 45:631.
48. Ward, S. G., Wilson, A., Turner, L., Westwick, J. and Sansom, D. M. 1995. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25:526.
49. ras with phosphatidylinositol 3-kinase. Proc. Natl Acad. Sci. USA 88:7908.
50. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. 1994. Phosphatidyl-3-OH kinase as a direct target of Ras. Nature 370:527.
51. Hu, Q., Kuppel, A., Muslin, A. J., Fantl, W. J. and Williams, L. T. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100.
52. Tolias, K. F., Cantley, L. C. and Carpenter, C. L. 1995. Rho family GTPases bind to phosphoinositide kinases. J. Biol. Chem. 270:17656.
53. ras. J. Exp. Med. 180:1067.
54. Su, B., Kacinto, E., Hibi, M., Kallunki, T., Karin, M. and Ben-Neriah, Y. 1994. JNK is involved in signal transduction during the costimulation of T lymphocytes. Cell 77:727.
55. Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M. and Davis, R. J. 1994. JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025.
56. Rincon, M. and Flavell, R. A. 1994. AP-1 transcriptional activity requires both T cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370.